Trend Report

United States Import Trends of HTS Code 3002.20.00.00 — Pharmaceutical ...
show more
Show details

3002.20.00.00 Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine

Trending Over Time: All Countries (USD)

Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)

$64,589,246.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-01 $50,620,924.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-02 $83,964,312.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-03 $72,254,395.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-04 $83,800,332.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-05 $93,204,383.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-06 $151,386,339.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-07 $175,209,787.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-08 $254,971,959.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-09 $219,860,859.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-10 $359,122,389.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-11 $418,135,635.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2009-12 $226,428,585.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-01 $173,401,719.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-02 $178,031,714.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-03 $61,209,781.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-04 $82,470,143.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-05 $157,839,105.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-06 $262,446,343.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-07 $382,206,289.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-08 $232,362,721.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-09 $130,494,466.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-10 $43,725,856.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-11 $75,287,254.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2010-12 $112,842,232.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-01 $149,497,381.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-02 $179,252,725.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-03 $115,768,477.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-04 $138,129,611.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-05 $125,778,096.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-06 $222,818,777.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-07 $333,708,441.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-08 $158,688,561.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-09 $213,421,847.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-10 $146,507,844.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-11 $100,324,951.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2011-12 $101,152,115.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-01 $83,772,390.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-02 $167,173,565.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-03 $122,708,743.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-04 $108,376,474.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-05 $123,523,123.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-06 $160,461,287.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-07 $301,186,432.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-08 $164,091,572.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-09 $149,084,316.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-10 $88,745,864.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-11 $160,414,094.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2012-12 $167,643,873.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-01 $92,989,657.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-02 $91,709,538.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-03 $117,265,315.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-04 $235,948,418.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-05 $295,880,864.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-06 $282,382,941.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-07 $274,247,679.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-08 $399,581,472.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-09 $389,188,952.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-10 $244,704,378.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-11 $131,500,262.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2013-12 $127,042,838.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2014-01 $123,142,333.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine imported by the US in 2014-02

Value of Goods Entering US in last year (USD)

Top 10 suppliers
Belgium $920,557,945
Ireland $592,467,316
Canada $263,092,984
United Kingdom $222,158,037
Germany $178,767,852
Subscribers only $167,979,156
Subscribers only $91,537,938
Australia $60,800,015
Subscribers only $4,894,136
Subscribers only $683,121

Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)

Belgium exported $920,557,945.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Ireland exported $592,467,316.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Canada exported $263,092,984.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. United Kingdom exported $222,158,037.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Germany exported $178,767,852.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $167,979,156.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $91,537,938.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. Australia exported $60,800,015.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $4,894,136.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $683,121.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $632,921.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $16,525.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. India exported $15,429.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $8,640.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $5,462.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US. A country, available to Panjiva subscribers, exported $2,660.00 of HTS Code 3002.20.00.00 — pharmaceutical products: human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: vaccines for human medicine to the US.

Change in Market Share in last year

Largest Change
Ireland 22.1%
Italy 1.5%
Subscribers only -13.4%
Subscribers only -3.2%
Subscribers only -3.2%
Subscribers only -1.6%
Subscribers only -0.8%
Germany -0.8%
Switzerland -0.3%
Denmark -0.2%

Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)

Ireland increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 22.053%.
Italy increased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by 1.465%.

Denmark decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -0.187%.
Switzerland decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -0.289%.
Germany decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -0.792%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -0.841%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -1.574%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -3.168%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -3.214%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3002.20.00.00 — vaccines for human medicine to the US by -13.399%.

Heatmap Key

Top Global Suppliers (in $1,000 exported)

                      2009                       2010                       2011                       2012              
Country Trend Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb
 
All sparkline   64,589 50,621 83,964 72,254 83,800 93,204 151,386 175,210 254,972 219,861 359,122 418,136 226,429 173,402 178,032 61,210 82,470 157,839 262,446 382,206 232,363 130,494 43,726 75,287 112,842 149,497 179,253 115,768 138,130 125,778 222,819 333,708 158,689 213,422 146,508 100,325 101,152 83,772 167,174 122,709 108,376 123,523 160,461 301,186 164,092 149,084 88,746 160,414 167,644 92,990 91,710 117,265 235,948 295,881 282,383 274,248 399,581 389,189 244,704 131,500 127,043 123,142  
1. Belgium sparkline   43,238 27,643 51,664 31,338 47,026 47,896 75,459 42,542 58,982 20,065 61,848 76,814 50,732 97,899 90,560 19,991 40,060 71,768 67,597 77,691 78,194 64,934 32,679 35,872 63,852 103,380 149,494 48,897 79,723 51,521 73,698 111,691 60,274 129,689 63,824 24,915 54,914 40,490 88,616 58,873 52,389 59,976 59,243 117,119 74,110 67,625 43,565 100,427 131,659 50,121 25,626 47,431 79,726 102,751 79,174 106,456 136,979 116,192 119,997 34,162 75,338 69,782  
2. Canada sparkline   10,426 10,931 18,538 14,631 21,040 16,255 36,458 24,273 54,324 35,975 120,736 162,224 98,686 54,051 40,977 17,221 11,411 37,553 71,320 82,740 11,248 22,717 581 31,657 24,739 21,088 15,997 26,030 19,514 32,432 53,051 53,766 43,849 34,004 37,703 29,366 34,067 22,122 22,523 16,153 21,027 25,405 38,278 33,344 12,001 27,338 10,655 17,542 18,918 8,545 11,773 17,223 29,102 10,714 20,434 40,023 9,571 55,038 19,221 29,010 25,955 24,024  
3. United Kingdom sparkline   5.80 0 55 0 1,503 16 2,147 46,402 113,055 116,690 156,132 153,461 62,766 4,145 4,691 13,298 9,999 25,151 84,522 189,177 80,775 0 3,679 0 482 41 3,024 4,531 10,366 25,798 45,992 134,324 23,465 5,681 19 1,798 977 0 5,482 4,084 11,067 9,467 12,969 94,853 52,941 17,058 2,360 6,858 5.18 356 4,167 13,106 13,956 7,756 13,039 72,415 73,239 34,939 0 120 4,691 2,004  
4. France sparkline   8,798 8,444 8,459 21,611 10,228 15,951 15,585 14,044 20,887 18,375 25 9,219 7,226 16,689 25,259 5,513 9,310 11,950 16,330 8,400 11,769 21,313 2,989 7,439 21,309 22,823 3,512 14,880 23,144 12 12,068 8,378 15,502 23,824 5,800 26,093 5,124 6.91 13,493 27,551 18,292 4,088 19,164 17,251 3,458 11,187 13,511 19,525 3,504 15,906 29,501 10,490 18,602 6,332 12,617 25,439 28,304 26,319 9,375 17,140 6,844 17,007  
5. Ireland sparkline   0 0 0 4.37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79 0 11 6.75 7.12 13 20 7.83 0 4.67 14 21 0 50 0 14 0 154 15 62 153 68 22 8.25 4.50 18 7.29 0 3.47 15 6,497 46,818 125,912 122,318 9.28 92,647 141,382 63,366 2.32 9.74 2.92  
6. Subscribers only sparkline   0 3,599 3,878 3,423 3,413 765 3,285 30,201 5,034 15,169 19,783 7,316 5,815 568 0 0 8,956 8,519 933 17,048 31,832 16,185 0 9.56 0 2,130 644 3,039 3,501 25 8,881 1,289 1,777 10,600 24,508 17,318 4,813 3,853 19,644 15,363 3,466 15,382 7,681 11,510 19,581 4,456 16,847 10,421 5,118 9,929 6,847 2,218 12,601 87 11,302 9,322 38,452 7,266 32,472 48,850 12,696 5,720  
7. Subscribers only sparkline   916 0 47 0 0 0 0 0 0 46 543 1,259 0 0 14,369 5,187 0 25 20,822 180 3,474 4.02 2,874 299 1,889 0 6,406 18,321 0 2,121 8,918 5,194 12,520 9,624 12,880 784 0 17,174 16,380 640 0 0 0 0 65 19,689 1,775 45 7,572 7,793 12,964 16,271 33,483 26,893 1,239 0 17,135 7,245 273 0 675 4,596  
8. Australia sparkline   0 0 0 0 0 11,718 16,282 17,684 2,159 11,525 53 7,024 94 2.97 0 0 772 2,119 0 6,236 13,934 3,196 0 0 0 0 0 0 1,185 13,202 19,441 18,315 638 0 0 38 0 62 0 21 0 7,589 23,046 23,137 1,867 0 0 0 0 19 0 0 1,650 14,941 22,157 20,386 802 41 0 823 0 0  
9. Subscribers only sparkline   1,205 0 602 1,205 0 602 602 0 0 1,205 0 0 566 0 1,448 0 817 752 897 0 1,132 29 922 0 564 0 163 0 680 631 654 655 635 0 0 0 1,132 0 876 0 2,069 1,460 0 3,069 0 1,726 0 1,691 818 0 818 4,030 0 0 0 14 2,453 491 0 1,118 818 0  
10. Subscribers only sparkline   0 0 697 0 0 0 1,558 10 0 796 0 809 0 0 727 0 0 0 0 736 0 718 0 0 0 0 0 0 0 0 2.16 0 0 0 0 5.00 0 4.22 0 0 0 0 0 0 0 0 0 3,835 0 0 0 0 0 484 0 170 0 4.35 0 24 0 0  
11. Subscribers only sparkline   0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 0 5.01 0 26 0 0 1,390 0 0 0 0 0 0 0 0 0 0 0 0 1,723 6.82 0 0 0 0 0 2.78 0 871 0 0 0 0 0 2.48 0 0 0 0 0 0 0 0 0 0 0 0  
12. Subscribers only sparkline   0 0 0 0 455 0 0 0 510 0 0 0 545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.16 2.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70 0 0 0 0 0 0 0 0 0 0 17 0  
13. Austria sparkline   0 0 0 0 126 0 0 51 0 13 0 0 0 41 0 0 0 0 0 0 0 0 0 0 0 30 0 50 0 31 0 0 7.50 0 0 0 0 0 0 0 0 0 0 0 0 0 15 47 0 305 0 0 0 7.50 103 2.12 0 270 0 250 0 0  
14. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1,100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
15. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 60 0 0 0 0 3.04 0 58 0 0 17 51 0 0 0 11 4.00 0 0 0 0 0 0 0 0  
16. Subscribers only sparkline   0 0 0 0 0 0 8.75 0 21 0 0 5.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 111 0 0 0 0 0 10 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
17. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.81 0 109 0 0 0 0 0 0 0 0 8.59 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.64 0 0 0 0 0 0  
18. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
19. Subscribers only sparkline   0 0 0 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
20. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 5.28 0 0 0 0 36 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
21. South Africa sparkline   0 2.88 0 2.16 9.54 0 0 2.38 0 0 3.18 0 0 0 0 0 3.63 2.96 0 0 0 0 2.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.36 0 0 0 0 0 0 0 0 0 0 2.66 0 0 0 0 0 0  
22. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.32 0 0 0 0 0 0 0 0 4.95 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
23. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 6.50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
24. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.46  
25. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
26. Subscribers only sparkline   0 0 0 0 0 0 0 0 0 2.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
* n/a denotes missing data

Panjiva Trends -Quarterly Report

The complete Panjiva Trends Quarterly Report, complete with country and commodity analysis is now available for free download.